Jim Dillon
About Jim Dillon
Jim Dillon President and CEO of BioVentrix
Jim Dillon has held the position of President and CEO at BioVentrix since April 2021. In this role, he is responsible for overseeing all company operations, strategic planning, and overall business growth. His leadership focuses on advancing BioVentrix's mission to develop innovative therapies for heart failure patients.
Jim Dillon's Experience in Heart Failure Therapy Companies
Jim Dillon brings significant experience to his role at BioVentrix, particularly in the realm of heart failure therapy. He has a history of leading companies that develop groundbreaking treatments in this specialized medical field. His expertise is instrumental in driving advancements and fostering innovation within BioVentrix.